Hani Gabra

7PUBLICATIONS
40CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Chemical and thermal processes in energy and combustionCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 23, 2025
Bioinformatic RNA-Seq Functional Profiling of the Tumor Suppressor Gene OPCML in Ovarian Cancers: The Multifunctional, Pleiotropic Impacts of Having Three Ig Domains.

Adam G Marsh, Franziska Görtler, Sassan Hafizi

|Mar 20, 2021
A Phase Ib Open-Label, Dose-Escalation Study of NUC-1031 in Combination with Carboplatin for Recurrent Ovarian Cancer.

Farasat Kazmi, Shibani Nicum, Rene L Roux

|Mar 06, 2021
Endogenous aldehyde accumulation generates genotoxicity and exhaled biomarkers in esophageal adenocarcinoma.

Stefan Antonowicz, Zsolt Bodai, Tom Wiggins

|Feb 27, 2020
Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management.

Megan Rumford, Mark Lythgoe, Iain McNeish

|Oct 02, 2019
Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.

Jessica M Winfield, Jennifer C Wakefield, David Dolling

|Jul 19, 2019
Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions.

James R Birtley, Mohammad Alomary, Elisa Zanini

Pageof 2

Frequent Collaborators

2 joint publications

Jane Antony

2 joint publications

Chiara Recchi

1 joint publications

Elisa Zanini

1 joint publications

Tuan Zea Tan